Selbyville, Delaware, May 07, 2020 (GLOBE NEWSWIRE) -- The global cardiac biomarker diagnostic kits market recorded a valuation of USD 2.33 billion in 2019 and is estimated to reach USD 3.37 billion by 2026, increasing at a CAGR of 5.4 per cent over 2019-2026. Mounting prevalence of cardiovascular disease globally are likely to drive the adoption of cardiac biomarker kits in the upcoming years. In addition to this, expanding geriatric population in emerging economies worldwide is poised to drive the worldwide cardiac biomarker kits industry.
The market study is bifurcated into different segments including product types, end-users and competitive landscape. Moreover, the study also includes individual market shares, current and projected growth rates, recent technological developments, and drivers across the aforementioned segments.
The challenges and restraints that might impede the growth of the industry have been presented in the report. Additionally, the study is inclusive of the opportunities in micro markets that industry vendors can take note of and tap accordingly.
Cardiac biomarker diagnostic kits constitute various tools and instruments that are used to detect and evaluate heart functions. They play a pivotal role in early diagnosis and prediction of heart related diseases and offer favorable benefits in initial diagnosis of heart disease and carry the capability of evaluating significant treatment of these diseases.
Request Sample copy of this Report @ https://www.marketstudyreport.com/request-a-sample/2610796/
According to estimates by the World Health Organization, cardiovascular diseases are named as one of the primary reasons for the number of deaths globally. In fact, estimates claim that cardiovascular disorders account for nearly 17.9 million or over 31 per cent of worldwide deaths annually. It has been reported that over more than 75 per cent of the deaths occur in low and middle-income countries whilst over 85 per cent of deaths are a result of severe heart attacks and strokes.
One of the restraining factors hampering the growth of cardiac biomarker diagnostic kits market is the high production cost associated with these products.
Overall cardiac biomarker kits industry is diversified into various geographies including Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America has emerged has one of the leading regions in the cardiac biomarker kits industry owing to increasing disposable incomes of the population in line with the rising investment in healthcare sector in the region. More so, Asia Pacific is anticipated to stand as the second largest revenue generating ground for the industry due to robust growth in the prevalence of cardiovascular diseases and presence of ageing population across the region.
To access a sample copy or view this report in detail along with the table of contents, please click the link below:
The worldwide cardiac biomarker kits industry is divided on the basis of product types, end-users, regions, and competitive landscape.
Cardiac Biomarker Kits Market Product Type Analysis (Revenue, USD Million, 2016-2026)
Cardiac Biomarker Kits Market End-User Analysis (Revenue, USD Million, 2016-2026)
Cardiac Biomarker Kits Market Regional Analysis (Revenue, USD Million, 2016-2026)
North America
Europe
Asia Pacific
Latin America
Rest of the World
Cardiac Biomarker Kits Market Type Analysis (Revenue, USD Million, 2016-2026)
Table of content:
Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2018-2026 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Cardiac Biomarker Diagnostic Kit Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Cardiac Biomarker Diagnostic Kit Market Dynamics
3.1. Cardiac Biomarker Diagnostic Kit Market Impact Analysis (2018-2026)
3.1.1. Market Drivers
3.1.2. Market Challenges
3.1.3. Market Opportunities
Chapter 4. Global Cardiac Biomarker Diagnostic Kit Market Industry Analysis
4.1. Porter’s 5 Force Model
4.2. PEST Analysis
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
Chapter 5. Global Cardiac Biomarker Diagnostic Kit Market, by Product Type
5.1. Market Snapshot
5.2. Global Cardiac Biomarker Diagnostic Kit Market by Product Type, Performance - Potential Analysis
5.3. Global Cardiac Biomarker Diagnostic Kit Market Estimates & Forecasts by Product Type 2016-2026 (USD Billion)
5.4. Cardiac Biomarker Diagnostic Kit Market, Sub Segment Analysis
5.4.1. Reagents and Kits
5.4.2. Instruments
5.4.3. Chemiluminescence
5.4.4. Immunofluorescence
5.4.5. Elisa
5.4.6. Immunochromatography
Chapter 6. Global Cardiac Biomarker Diagnostic Kit Market, by Diseases Indication
6.1. Market Snapshot
6.2. Global Cardiac Biomarker Diagnostic Kit Market by Diseases Indication, Performance - Potential Analysis
6.3. Global Cardiac Biomarker Diagnostic Kit Market Estimates & Forecasts by Diseases Indication 2016-2026 (USD Billion)
6.4. Cardiac Biomarker Diagnostic Kit Market, Sub Segment Analysis
6.4.1. Angina Pectoris
6.4.2. Myocardial Infraction
6.4.3. Cardiac Heart Failure
6.4.4. Others
Chapter 7. Global Cardiac Biomarker Diagnostic Kit Market, by End-User
7.1. Market Snapshot
7.2. Global Cardiac Biomarker Diagnostic Kit Market by End-User, Performance - Potential Analysis
7.3. Global Cardiac Biomarker Diagnostic Kit Market Estimates & Forecasts by End-User 2016-2026 (USD Billion)
7.4. Cardiac Biomarker Diagnostic Kit Market, Sub Segment Analysis
7.4.1. Hospitals
7.4.2. Diagnostic Centres
7.4.3. Clinics
Chapter 8. Global Cardiac Biomarker Diagnostic Kit Market, Regional Analysis
Chapter 9. Competitive Intelligence
Related Report:
In-Vitro Colorectal Cancer Screening Tests Market Share & Forecast to 2024
In-Vitro Colorectal Cancer Screening Tests market will exceed USD 1 billion by 2024; as per a new research report. Increasing incidences of colorectal cancer coupled with rising demand for non-invasive cancer screening tests will drive in-vitro colorectal cancer screening tests market over the forecast period. Growing geriatric population base, highly susceptible to suffer from colorectal cancer will further propel market growth.
Growing adoption of sedentary lifestyle, unhealthy dietary habits along with increased tobacco smoking and alcohol consumption has escalated number of people suffering from inflammatory intestinal conditions. Thus, leading to rise in colorectal cancer cases. Numerous initiatives undertaken by public as well as private players to create awareness about pre-diagnosis and treatment of colon and rectal cancer will favor industry growth.
About US:
Market Study Report, LLC. is a hub for market intelligence products and services.
We streamline the purchase of your market research reports and services through a single integrated platform by bringing all the major publishers and their services at one place.
Our customers partner with Market Study Report, LLC. to ease their search and evaluation of market intelligence products and services and in turn focus on their company's core activities.
If you are looking for research reports on global or regional markets, competitive information, emerging markets and trends or just looking to stay on top of the curve then Market Study Report, LLC. is the platform that can help you in achieving any of these objectives.
Contact Us: Corporate Sales, Market Study Report LLC Phone: 1-302-273-0910 Toll Free: 1-866-764-2150 Email: sales@marketstudyreport.com